Week in Review
Top highlights this week include: NIH wants 1 million Americans to contribute to new pool of gene data, easily affordable whole-genome sequencing, newly FDA-approved platform will rapidly manufacture stem cells to repair our bodies, high-sensitivity troponin may help uncover heart failure rise, and preventing colds and flu.
Top highlights this week include: More cases reported in deadly U.S. “E. coli” outbreak, deadly flu season, ibuprofen linked to male infertility, memory problems and dementia, elevated high-sensitivity cardiac troponin can point to impending heart failure, and Mayo Clinic receives high marks for hospital quality from federal government.
Top highlights this week include: Hazards of the post-new year’s rush to gyms, three brain technologies to watch for in 2018, the effect of a strong immune system on colds and flu, dangers of frostbite, and top tests and health checks for the New Year.
Top highlights this week include: Nutrients in leafy greens may help prevent dementia, U.S. life expectancy declines for a second straight year, migraine prevention, innovative research to fight kidney disease, and greater access to donated livers.
Top highlights this week include: 10 medical advances that raised our hopes in 2017, medical advances to watch for in 2018, first genome-wide association study of dementia with Lewy bodies, cancer survivors face faster aging, and three tips for flu prevention.
Top highlights this week include: Huntington’s breakthrough may stop disease, DNA is going digital, Mayo Clinic study identifies barriers to stem cell therapy, genetic model predicts primary myelofibrosis outcomes, and first U.S. baby born after uterus transplantation is dawn of a new era.
Top highlights this week include: Flu is spreading fast this year, antibiotic resistance, Mayo Clinic develops test to distinguish other demyelinating diseases from MS, first U.S. baby born after a uterus transplant, and replacing awful hospital lighting.
Top highlights this week include: Scarlet fever cases rise, nearly half of U.S. cancer deaths blamed on unhealthy behavior, new Mayo Clinic neuro test distinguishes IDDs from multiple sclerosis, aging neurosurgeons, and making Type 1 diabetes management easier.
Top highlights this week include: They’re taking your blood pressure all wrong, heavier women may need mammograms more often, diabetes’ connection to pancreatic cancer, helping obese kids avoid weight stigma, and research shows newer blood thinners have lower risk of kidney function decline.
Top highlights this week include: Rise in teen suicide and social media coincide, U.S. scientists try first gene editing in the body, half of U.S. adults have high blood pressure in new guidelines, researchers are one step closer to helping advanced prostate cancer patients, and how individualized medicine is spreading to opioid prescriptions.
Top highlights this week include: Moderate alcohol consumption may increase risk of certain cancers, low vitamin D may raise risk of kidney failure, treatment updates for patients with high-risk myeloma, genetic pathways to individualized treatment for advanced prostate cancer, and Mayo physician dispels popular coffee misconceptions.
Top highlights this week include: Soy might be good for your heart but it’s not definite, brain patterns may predict people at risk of suicide, health care leaders discuss solutions to industry issue, underutilized test may improve treatment decisions, outcomes in colon cancer, and Mayo Clinic researchers find genetic pathways to individualized treatment for advanced prostate cancer.
Top highlights this week include: New gene-editing technique may lead to treatment for thousands of diseases, many breast cancer patients receive more radiation than needed, fewer lab tests can produce better patient results, Mayo Clinic planning $1.2 billion in capital spending in Rochester, and researchers link Alzheimer’s gene to Type 3 diabetes.